Zobrazeno 1 - 10
of 261
pro vyhledávání: '"Del Monte-Millán M"'
Autor:
Villacampa, G., Tung, N.M., Pernas, S., Paré, L., Bueno-Muiño, C., Echavarría, I., López-Tarruella, S., Roche-Molina, M., del Monte-Millán, M., Marín-Aguilera, M., Brasó-Maristany, F., Waks, A.G., Pascual, T., Martínez-Sáez, O., Vivancos, A., Conte, P.F., Guarneri, V., Vittoria Dieci, M., Griguolo, G., Cortés, J., Llombart-Cussac, A., Muñoz, M., Vidal, M., Adamo, B., Wolff, A.C., DeMichele, A., Villagrasa, P., Parker, J.S., Perou, C.M., Fernandez-Martinez, A., Carey, L.A., Mittendorf, E.A., Martín, M., Prat, A., Tolaney, S.M.
Publikováno v:
In Annals of Oncology
Autor:
Martín M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Yoder R; The University of Kansas Cancer Center, Westwood, Kansas., Salgado R; ZAS Hospitals, Antwerp, Belgium., Del Monte-Millán M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Álvarez EL; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Echavarría I; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Staley JM; The University of Kansas Cancer Center, Westwood, Kansas., O'Dea AP; University of Kansas Medical Center, Westwood, Kansas., Nye LE; University of Kansas Medical Center, Westwood, Kansas., Stecklein SR; University of Kansas Medical Center, Kansas City, Kansas., Bueno C; Hospital Infanta Cristina (Parla), Madrid, Spain., Jerez Y; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Cebollero M; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Bueno O; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., García Saenz JÁ; Hospital Clínico San Carlos, Madrid, Spain., Moreno F; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain., Bohn U; Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Canary Islands., Gómez H; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Massarrah T; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Khan QJ; University of Kansas Medical Center, Westwood, Kansas., Godwin AK; University of Kansas Medical Center, Kansas City, Kansas., López-Tarruella S; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Sharma P; University of Kansas Medical Center, Westwood, Kansas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2160-2169.
Autor:
Lopez-Tarruella S; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, 28007, Madrid, Spain., Del Monte-Millán M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc, Madrid, Spain., Roche-Molina M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Jerez Y; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc, Madrid, Spain., Echavarria Diaz-Guardamino I; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc, Madrid, Spain., Herrero López B; Medical Oncology Department, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Gamez Casado S; Medical Oncology Department, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Marquez-Rodas I; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc, Madrid, Spain., Alvarez E; Medical Oncology Department, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Cebollero M; Pathology Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Massarrah T; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CiberOnc, Madrid, Spain., Ocaña I; Medical Oncology Department, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., Arias A; Medical Oncology Department, Hospital General Universitario Gregorio Marañón Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain., García-Sáenz JÁ; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid, Spain., Moreno Anton F; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid, Spain., Olier Garate C; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Alcorcon, Spain., Moreno Muñoz D; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Alcorcon, Spain., Marrupe D; Department of Oncologia, Hospital Universitario de Móstoles, Mostoles, Spain., Lara Álvarez MÁ; Medical Oncology Department, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Enrech S; Medical Oncology Department, Hospital Universitario de Getafe, Madrid, Spain., Bueno Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, 28009, Madrid, Spain., Martín M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Geicam, Universidad Complutense, 28007, Madrid, Spain. mmartin@geicam.org.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jan; Vol. 203 (1), pp. 163-172. Date of Electronic Publication: 2023 Sep 29.
Autor:
Diaz-Guardamino, I. Echavarria, Lopez-Tarruella Cobo, S., Del Monte-Millan, M., Alvarez, E., Gilarranz, Y. Jerez, Anton, F. Moreno, Saenz, J.Á. García, Massarrah, T., Ocaña, I., Cebollero, M., Garcia, A.I. Ballesteros, Sarmiento, U. Bohn, Gomez, H., Rivera, H. Fuentes, Lopez, B. Herrero, Polo, C., Bueno, O., Rahimi, P., Muiño, C. Bueno, Jimenez, M. Martin
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S324-S325
Autor:
Jimenez, M. Martin, Gluz, O., Villacampa, G., Lopez-Tarruella Cobo, S., Nitz, U.A., Cobo, S., Brasó-Maristany, F., Christgen, M., Gilarranz, Y. Jerez, Kummel, S., Conte, B., Diaz-Guardamino, I. Echavarria, Graeser-Mayer, M.K., Kreipe, H., Del Monte-Millan, M., Lopez, B. Herrero, Perou, C.M., Brunet, L. Pare, Prat, A., Harbeck, N.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S312-S312
Autor:
Martín Lozano, R., Roche-Molina, M., Alvarez, E., Del Monte-Millan, M., Jerez Gilarranz, Y., Moreno Anton, F., García Saenz, J.Á., Echavarria Diaz-Guardamino, I., Massarrah, T., Cebollero, M., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Gomez Moreno, H.L., Fuentes, H.A., Herrero Lopez, B., Gamez Casado, S., Bueno Muiño, C., Bueno, O., Lopez-Tarruella Cobo, S., Martin Jimenez, M.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, Madrid, Spain., Echavarría I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Geicam, Universidad Complutense, Madrid, Spain., Roche-Molina M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Del Monte-Millán M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Massarrah T; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Jerez Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain., Ayala de la Peña F; Hematology and Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain., García-Sáenz JÁ; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos, CIBERONC, Madrid, Spain., Moreno F; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos, CIBERONC, Madrid, Spain., Rodríguez-Lescure Á; Medical Oncology Department, General Universitario de Elche, Alicante, Spain., Malón-Giménez D; Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain., Ballesteros García AI; Department of Medical Oncology, Hospital Universitario de La Princesa, Madrid, Spain., Marín-Aguilera M; Reveal Genomics, Barcelona, Spain., Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain., Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts., Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Villagrasa P; Reveal Genomics, Barcelona, Spain., Parker JS; Department of Genetics, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill., Perou CM; Department of Genetics, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill., Paré L; Reveal Genomics, Barcelona, Spain., Villacampa G; Reveal Genomics, Barcelona, Spain., Prat A; Reveal Genomics, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Spain.; Institute of Oncology-Quirón, Barcelona, Spain., Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Geicam, Universidad Complutense, Madrid, Spain.
Publikováno v:
JAMA oncology [JAMA Oncol] 2023 Jun 01; Vol. 9 (6), pp. 841-846.
Autor:
Gottipati, S., Earl, H.M., Yau, C., Cameron, D.A., Abraham, J., Hayward, L., Reyal, F., Osdoit, M., Sonke, G.S., Wesseling, J., Boughey, J., Goetz, M.P., DeMichele, A., Pusztai, L., Sharma, P., Jimenez, M. Martin, Lopez-Tarruella Cobo, S., Del Monte-Millan, M., Symmans, F., Mukhtar, R.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S325-S326
Autor:
Bringas Beranek, M., Echavarria Diaz-Guardamino, I., Polo, C., Flores Sanchez, C., Munoz Martin, A.J., Ortega Morán, L., Herrero Lopez, B., Calvo Ferrandiz, P.A., Jerez Gilarranz, Y., Torres Perez-Solero, G., Lopez-Tarruella Cobo, S., Gamez Casado, S., Perez Ramirez, S., Veiga Fernández, A., Pajares, J.A., Sanz, M., Suarez, J., Del Monte-Millan, M., Martin Jimenez, M., Marquez-Rodas, I.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S274-S275
Autor:
Gutierrez Alonso, N., Benavente, M., Bringas Beranek, M., Soto Alsar, J., Palma, M., Cañete Muñoz, M.A., Lopez Alfonso, A., Rahimi Mousavi, P., Roche-Molina, M., Del Monte-Millan, M., Megias, D., García Pérez, Á., Mullor Delgado, L.A., Ortega Morán, L., Torres Perez-Solero, G., Morón, B.I., Calvo Ferrandiz, P.A., García Alfonso, P., Martin Jimenez, M., Munoz Martin, A.J.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S912-S912